376 related articles for article (PubMed ID: 24896566)
1. Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?
Niego B; Medcalf RL
J Cereb Blood Flow Metab; 2014 Aug; 34(8):1283-96. PubMed ID: 24896566
[TBL] [Abstract][Full Text] [Related]
2. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
[TBL] [Abstract][Full Text] [Related]
3. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
[TBL] [Abstract][Full Text] [Related]
4. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
Liu W; Hendren J; Qin XJ; Liu KJ
Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
[TBL] [Abstract][Full Text] [Related]
5. Remote ischemic conditioning attenuates blood-brain barrier disruption after recombinant tissue plasminogen activator treatment via reducing PDGF-CC.
He Q; Ma Y; Fang C; Deng Z; Wang F; Qu Y; Yin M; Zhao R; Zhang D; Guo F; Yang Y; Chang J; Guo ZN
Pharmacol Res; 2023 Jan; 187():106641. PubMed ID: 36587812
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
[TBL] [Abstract][Full Text] [Related]
7. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
Won S; Lee JH; Wali B; Stein DG; Sayeed I
J Cereb Blood Flow Metab; 2014 Jan; 34(1):72-80. PubMed ID: 24045404
[TBL] [Abstract][Full Text] [Related]
8. Comparison of plasmin with recombinant tissue-type plasminogen activator in lysis of cerebral thromboemboli retrieved from patients with acute ischemic stroke.
Marder VJ; Blinc A; Gruber T; Tratar G; Sabovic M; Starkman S; Jahan R; Duckwiler G; Vinuela F; Tateshima S; Liebeskind D; Ovbiagele B; Ali L; Kim D; Gonzalez N; Vespa PM; Saver JL
Stroke; 2011 Aug; 42(8):2222-8. PubMed ID: 21700944
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cell-derived extracellular vesicles attenuate tPA-induced blood-brain barrier disruption in murine ischemic stroke models.
Qiu L; Cai Y; Geng Y; Yao X; Wang L; Cao H; Zhang X; Wu Q; Kong D; Ding D; Shi Y; Wang Y; Wu J
Acta Biomater; 2022 Dec; 154():424-442. PubMed ID: 36367475
[TBL] [Abstract][Full Text] [Related]
10. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
[TBL] [Abstract][Full Text] [Related]
11. Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.
Jean LeBlanc N; Menet R; Picard K; Parent G; Tremblay MÈ; ElAli A
Mol Neurobiol; 2019 Sep; 56(9):6521-6538. PubMed ID: 30852795
[TBL] [Abstract][Full Text] [Related]
12. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
[TBL] [Abstract][Full Text] [Related]
13. The smoking-thrombolysis paradox and acute ischemic stroke.
Fisher M
Neurology; 2006 Feb; 66(3):458; author reply 458. PubMed ID: 16476964
[No Abstract] [Full Text] [Related]
14. Xenon is an inhibitor of tissue-plasminogen activator: adverse and beneficial effects in a rat model of thromboembolic stroke.
David HN; Haelewyn B; Risso JJ; Colloc'h N; Abraini JH
J Cereb Blood Flow Metab; 2010 Apr; 30(4):718-28. PubMed ID: 20087367
[TBL] [Abstract][Full Text] [Related]
15. Novel situations of endothelial injury in stroke--mechanisms of stroke and strategy of drug development: novel mechanism of the expression and amplification of cell surface-associated fibrinolytic activity demonstrated by real-time imaging analysis.
Suzuki Y; Urano T
J Pharmacol Sci; 2011; 116(1):19-24. PubMed ID: 21498960
[TBL] [Abstract][Full Text] [Related]
16. Combination approaches to attenuate hemorrhagic transformation after tPA thrombolytic therapy in patients with poststroke hyperglycemia/diabetes.
Fan X; Jiang Y; Yu Z; Yuan J; Sun X; Xiang S; Lo EH; Wang X
Adv Pharmacol; 2014; 71():391-410. PubMed ID: 25307224
[TBL] [Abstract][Full Text] [Related]
17. Fibrin-modifying serine proteases thrombin, tPA, and plasmin in ischemic stroke: a review.
Sheehan JJ; Tsirka SE
Glia; 2005 Jun; 50(4):340-350. PubMed ID: 15846799
[TBL] [Abstract][Full Text] [Related]
18. YangXueQingNaoWan attenuated blood brain barrier disruption after thrombolysis with tissue plasminogen activator in ischemia stroke.
Yao SQ; Ye Y; Li Q; Wang XY; Yan L; Huo XM; Pan CS; Fu Y; Liu J; Han JY
J Ethnopharmacol; 2024 Jan; 318(Pt B):117024. PubMed ID: 37572928
[TBL] [Abstract][Full Text] [Related]
19. Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly.
Kaur J; Tuor UI; Zhao Z; Barber PA
J Cereb Blood Flow Metab; 2011 Sep; 31(9):1874-85. PubMed ID: 21610723
[TBL] [Abstract][Full Text] [Related]
20. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]